HongKong Berry Genomics Co. Limited

Berry Genomics is one of the leading genetic services providers in Mainland China. It entered Hong Kong in 2015 as HongKong Berry Genomics Co. Limited with the sole purpose of investing into Xcelom Limited, a startup established in 2014. Xcelom is the exclusive licensee and provider of the Non-Invasive Prenatal Testing (NIPT) patented service from the Chinese University of Hong Kong. NIPT has redefined traditional prenatal screening and has been adopted worldwide for an improved screening of fetal chromosomal abnormality.

Xcelom has grown exponentially, gaining extensive support from medical professionals and the public for the services offered by its team of experts and state of the art laboratory. Xcelom will strive to expand the spectrum of testing services offered; from Whole Exome Sequencing, Whole Genome Sequencing, allergy testing to many more.

Xcelom is currently one of the largest local genetic testing services providers. Abided by international standards, it looks to expand into the overseas market in the near future.